<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Blood Transfus</journal-id>
<journal-id journal-id-type="iso-abbrev">Blood Transfus</journal-id>
<journal-id journal-id-type="publisher-id">SIMTI</journal-id>
<journal-title-group>
<journal-title>Blood Transfusion</journal-title>
</journal-title-group>
<issn pub-type="ppub">1723-2007</issn>
<publisher>
<publisher-name>Edizioni SIMTI - SIMTI Servizi Srl</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26057490</article-id>
<article-id pub-id-type="pmc">4624539</article-id>
<article-id pub-id-type="doi">10.2450/2015.0321-14</article-id>
<article-id pub-id-type="publisher-id">blt-13-622</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bakija</surname>
<given-names>Alenka Trampuš</given-names>
</name>
<xref ref-type="aff" rid="af1-blt-13-622">1</xref>
<xref ref-type="corresp" rid="c1-blt-13-622"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Debeljak</surname>
<given-names>Maruša</given-names>
</name>
<xref ref-type="aff" rid="af1-blt-13-622">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zupan</surname>
<given-names>Irena Preložnik</given-names>
</name>
<xref ref-type="aff" rid="af2-blt-13-622">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dolničar</surname>
<given-names>Majda Benedik</given-names>
</name>
<xref ref-type="aff" rid="af3-blt-13-622">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kovač</surname>
<given-names>Jernej</given-names>
</name>
<xref ref-type="aff" rid="af1-blt-13-622">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jazbec</surname>
<given-names>Janez</given-names>
</name>
<xref ref-type="aff" rid="af3-blt-13-622">3</xref>
</contrib>
</contrib-group>
<aff id="af1-blt-13-622"><label>1</label>Unit for Special Laboratory Diagnostics, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia</aff>
<aff id="af2-blt-13-622"><label>2</label>Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia</aff>
<aff id="af3-blt-13-622"><label>3</label>Unit for Haematology and Oncology, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia</aff>
<author-notes>
<corresp id="c1-blt-13-622">Correspondence: Alenka Trampuš Bakija, Unit for Special Laboratory Diagnostics, University Children’s Hospital, University Medical Centre Ljubljana, Bohoričeva 20, 1000 Ljubljana, Slovenia, e-mail: <email>alenka.trampus@guest.arnes.si</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>15</day>
<month>5</month>
<year>2015</year>
</pub-date>
<volume>13</volume>
<issue>4</issue>
<fpage>622</fpage>
<lpage>630</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>12</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>2</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© SIMTI Servizi Srl</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Heterogeneous bleeding phenotypes are observed in haemophilia A patients with the same mutation in the <italic>F8</italic> gene. Specific mutations in the A2 domain of factor VIII are associated with mild haemophilia and a higher risk of inhibitor development. Double mutations in mild haemophilia A are rarely reported. In this study, we investigated the <italic>in vitro</italic> function of factor VIII, performing different specific and global coagulation assays, observed clinical characteristics and assessed the possible predictive diagnostic value of the differences.</p>
</sec>
<sec>
<title>Materials and methods</title>
<p>The clinical features of haemophiliacs with a mild phenotype were reviewed. Blood samples were obtained and analysed for mutations and coagulation assays: activated partial thromboplastin time, one-stage and chromogenic factor VIII activity, factor VIII antigen and rotational thromboelastometry.</p>
</sec>
<sec>
<title>Results</title>
<p>We report on a cohort of 22 patients with double Glu113Asp, Arg593Cys mutations. All our patients have a quantitative defect of factor VIII and preserved similar functional activity. Factor VIII activities measured by the one-stage or chromogenic method were not discrepant, although the chromogenic assay resulted in 20% lower factor VIII activities. Waveform analysis showed a lower maximum value of the second derivative curve (Max2) of APTT with curve shape alternation, while thromboelastometry (INTEM) showed low sensitivity in comparison to results in a normal population.</p>
</sec>
<sec>
<title>Discussion</title>
<p>In genotyping, the coexistence of a second mutation should never be excluded, especially in cases of discordant clinical presentation. Waveform analysis correlates better with factor VIII activity than thromboelastometry and the Max2 parameter could provide additional information in managing haemophilia patients. The utility of specific factor activity and global haemostatic assays in general practice still needs to be investigated.</p>
</sec>
</abstract>
<kwd-group>
<kwd>mild haemophilia A</kwd>
<kwd>double mutation</kwd>
<kwd>FVIII assay</kwd>
<kwd>waveform analysis</kwd>
<kwd>thromboelastometry</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>